5+
Industry Recognition
800+
peer-reviewed publications
“We bridge the interface between academia, clinical medicine and drug development
We are at the forefront of leveraging human genetic data to unravel disease biology and inform all aspects of drug development. Our dedicated team is committed to delivering high-quality research that directly generates actionable and translatable insights for our clients and partners.
Dr. Dipender Gill, CEO Sequoia Genetics
Empowering Drug Development Through Genetic Insights
Founded in 2024, Sequoia Genetics is dedicated to transforming genetic data into actionable insights. Our mission is to collaborate with academia, investors, and the pharmaceutical and biotech industries to enhance drug discovery and development. We strive to be at the forefront of innovation, driving advancements that benefit healthcare.
Scientific Innovation & Discovery
Where Genetics Meets Drug Development
Our integrated scientific approach combines pioneering analytical methods with deep biological understanding — delivering evidence that is both rigorous and actionable at every stage of the development pipeline.
Our team has authored 800+ peer-reviewed publications and holds an H-index exceeding 100 — representing foundational contributions to Mendelian Randomization, cis-pQTL analysis, colocalization, and PheWAS. These are now standard practice across the industry. We lead, rather than follow, methodological advances in human genetics for drug discovery.
We go beyond statistical output. Every analysis includes biological interpretation and development context, designed to directly inform go/no-go decisions, trial design, indication selection, and investor diligence. Our evidence packages are communication-ready for both scientific and commercial audiences — from bench to boardroom.
Led by a practising cardiologist and built on multidisciplinary clinical science, Sequoia uniquely bridges genomic data and clinical reality. Our analyses are anchored in medical relevance — ensuring findings are interpretable and development-ready across cardiovascular, oncology, metabolic, and neurological indications.
Read Blogs
Strategies and Insights.
Developing personalized customer journeys to increase satisfaction and loyalty.
Our Clients
The common denominator for our clients is their interest in maximizing the impact of human genetic data to improve the probability of successfully developing effective therapies.
Pharma
Leveraging human genetics to transform complex biological data into actionable insights for drug discovery and development.
Biotech
Advancing breakthrough therapies through genetics-driven biotechnology and precision research.
Investors
Driving long-term value by investing in genetics-powered innovation and transformative healthcare solutions.
Academia
Empowering scientific discovery through collaborative research, education, and innovation in genetics.
